American Society of Clinical Oncology (ASCO) shared a post on X:
“For more on our recent rapid guideline update on the management of stage III NSCLC, based on the results of the phase 3 LAURA trial, ASCO Daily News has a detailed analysis and an interview with Expert Panel co-chair Navneet Singh.
Source: ASCO/X